Eight Roads Ventures India
25
36M
20
1.47
3
0.20
1
- Stages of investment
- Areas of investment
Summary
Eight Roads Ventures India is the famous VC, which was founded in 2007.
The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Eight Roads Ventures India the average startup value is 100-500 millions dollars. The high activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually.
We can highlight the next thriving fund investment areas, such as Enterprise Applications, Guides. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Whatfix, PharmEasy.
The overall number of key employees were 3.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Eight Roads Ventures India, startups are often financed by Eight Roads Ventures, Powerhouse Ventures, InnoVen Capital. The meaningful sponsors for the fund in investment in the same round are F-Prime Capital, Think Investments, Stellaris Venture Partners.
Investments analytics
Analytics
- Total investments
- 25
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 1.47
- Follow on index
- 0.20
- Investments by industry
- Health Care (8)
- Software (5)
- Biotechnology (5)
- E-Commerce (4)
- Artificial Intelligence (4) Show 47 more
- Investments by region
-
- India (15)
- United States (4)
- China (5)
- United Kingdom (1)
- Peak activity year
- 2022
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 367M
- Group Appearance index
- 1.00
- Avg. company exit year
- 15
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lanzhou Technology | 14 Mar 2023 | Artificial Intelligence | Seed | Beijing, Haidian, China | |
| PharmEasy | 26 Sep 2018 | Health Care, Health Diagnostics, Wellness, Pharmaceutical | Late Stage Venture | 50M | Maharashtra, Mumbai, India |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.